Researchers reflect on failure of Merck's HIV vaccine
This article was originally published in Scrip
Executive Summary
The failure of Merck'sHIV vaccine, MRK-Ad5 (MRKAd5 HIV-1 gag/pol/nef), to protect against HIV infection and which even led to increased susceptibility in some sub-groups in the STEP trial has been analysed by The Lancet in two papers and one commentary.